Saxena S P, Brandes L J, Becker A B, Simons K J, LaBella F S, Gerrard J M
Department of Pediatrics, University of Manitoba, Winnipeg, Canada.
Science. 1989 Mar 24;243(4898):1596-9. doi: 10.1126/science.2928797.
Inhibition of human platelet aggregation by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine-HCl (DPPE), a novel antagonist of histamine binding, suggested that histamine might serve a critical role in cell function. Phorbol-12-myristate-13-acetate (PMA) or collagen was found to increase platelet histamine content in parallel with promotion of aggregation. Inhibitors of histidine decarboxylase (HDC) suppressed both aggregation and the elevation of histamine content, whereas DPPE inhibited aggregation only. In saponin-permeabilized platelets, added histamine reversed the inhibition by DPPE or HDC inhibitors on aggregation induced by PMA or collagen. The results indicate a role for histamine as an intracellular messenger, which in platelets promotes aggregation.
新型组胺结合拮抗剂N,N - 二乙基 - 2 - [4 - (苄基)苯氧基]乙胺盐酸盐(DPPE)对人血小板聚集的抑制作用表明,组胺可能在细胞功能中起关键作用。发现佛波醇 - 12 - 肉豆蔻酸酯 - 13 - 乙酸酯(PMA)或胶原蛋白可增加血小板组胺含量,同时促进聚集。组氨酸脱羧酶(HDC)抑制剂可抑制聚集和组胺含量升高,而DPPE仅抑制聚集。在皂角苷通透的血小板中,添加的组胺可逆转DPPE或HDC抑制剂对PMA或胶原蛋白诱导的聚集的抑制作用。结果表明组胺作为细胞内信使发挥作用,在血小板中促进聚集。